新发类风湿关节炎20年随访:全因与心血管死亡趋势下降
该匹配病例队列研究纳入1994至2008年三个连续新发RA队列,每例匹配10名人群对照,随访至20年。1994至2003年诊断患者全因及心血管死亡率显著高于对照,而2004年后诊断队列未见死亡率增加,提示现代治疗策略可能改善RA患者生存。
要点
- 1994至2003年诊断RA患者10年后全因死亡率显著高于匹配对照。
- 早期队列心血管死亡率在5至10年后显著升高,2004年后队列未观察到此现象。
- 2004至2008年队列10年全因及心血管死亡率显著低于早期队列。
核心结论
- 1994至2003年诊断的RA患者全因和心血管死亡率较匹配对照显著增加,而2004年后诊断者未见增加。
- 结果可能提示现代治疗策略对RA患者死亡率有积极影响。
研究设计与样本
- 基于Oslo RA登记处的匹配病例队列研究,纳入1994至2008年发病且符合1987 ACR标准的RA患者。
- 每例患者匹配10名人群对照,并与挪威死因登记处链接。
- 采用分层Cox回归计算5、10、15及20年全因和心血管死亡风险比,多因素Cox回归估计死亡趋势。
主要发现
- 2004至2008年队列未观察到死亡率增加,其10年全因和心血管死亡率显著低于早期队列。
临床怎么用
- 对1994至2003年诊断的RA患者应关注远期全因及心血管死亡风险,尤其在病程10年后。
- 对早期诊断RA患者需重视心血管风险监测,心血管死亡风险在病程5年即可显著升高。
- 2004年后诊断患者死亡率未增加,支持现代治疗策略可能改善预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine all-cause and cardiovascular disease (CVD) mortality in consecutive cohorts of patients with incident RA, compared with population comparators. METHODS: The Oslo RA register inclusion criteria were diagnosis of RA (1987 ACR criteria) and residency in Oslo. Patients with disease onset 1994-2008 and 10 matched comparators for each case were linked to the Norwegian Cause of Death Registry. Hazard ratios for all-cause and CVD mortality were calculated for 5, 10, 15 and 20 years of observation using stratified cox-regression models. Mortality trends were estimated by multivariate cox-regression. RESULTS: 443, 479 and 469 cases with disease incidence in the periods 94-98, 99-03 and 04-08 were matched to 4430, 4790 and 4690 comparators, respectively. For cases diagnosed between 1994 and 2003, the all-cause mortality of cases diverged significantly from comparators after 10 years of disease duration [hazard ratio (95% CI) 94-98 cohort 1.42 (1.15-1.75): 99-03 cohort 1.37 (1.08-1.73)]. CVD related mortality was significantly increased after 5 years for the 94-98 cohort [hazard ratio (95% CI) 1.86 (1.16-2.98) and after 10 years for the 99-03 cohort 1.80 (1.20-2.70)]. Increased mortality was not observed in the 04-08 cohort where cases had significantly lower 10-year all-cause and CVD mortality compared with earlier cohorts. CONCLUSION: All-cause and CVD mortality were significantly increased in RA patients diagnosed from 1994 to 2003, compared with matched comparators, but not in patients diagnosed after 2004. This may indicate that modern treatment strategies have a positive impact on mortality in patients with RA.
引用
- Provan SA, Lillegraven S, Sexton J, et al. Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study. Rheumatology (Oxford). 2020. PMID: 31504942. doi:10.1093/rheumatology/kez371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。